Exhaled breath analysis for lung cancer detection using ion mobility spectrometry

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Ha, Hiroshi ^a   Usuba, Ayano ^a   Maddula, Sasidhar ^b   Baumbach, Jörg Ingo ^c   Mineshita, Masamichi ^a   Miyazawa, Teruomi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BandS Analytik BioMedicalCenter   (Germany)

^c REUTLINGEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DODECANE; EPIDERMAL GROWTH FACTOR RECEPTOR; VOLATILE ORGANIC COMPOUND; ALKANE; N-DODECANE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; BRONCHUS BIOPSY; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EXPIRED AIR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ION MOBILITY SPECTROMETRY; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; SPECTROMETER; SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; DECISION TREE; GENETICS; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; PROCEDURES; SMOKING; SPECTROSCOPY;

ADENOCARCINOMA; ADULT; AGED; ALKANES; BREATH TESTS; DECISION TREES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMOKING; SPECTRUM ANALYSIS; VOLATILE ORGANIC COMPOUNDS;

EID: 84916613270     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114555     Document Type: Article

References (45)

1. Gordon SM, Szidon JP, Krotoszynski K, Gibbons RD, O'Neill HJ (1985) Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem 31: 1278-1282.
2. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K, et al. (2003) Detection of lung cancer with volatile markers in the breath. Chest 123: 2115-23.
3. Di Natale C, Macagnano A, Martinelli E, Paolesse R, D'Arcangelo G, et al. (2003) Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron 18: 1209-1218.
4. Chen X, Cao M, Li Y, Hu W, Wang P, et al. (2005) A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors array and imaging recognition method. Meas Sci Technol 16: 1535-1546.
5. Machado RF, Laskowski D, Deffenderfer O, Burch T, Zheng S, et al. (2005) Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 171: 1286-1291.
6. Mazzone PJ, Hammel J, Dweik RA, Na J, Czich C, et al. (2007) Lung cancer diagnosis by the analysis of exhaled breath with a colorimetric sensor array. Thorax 62: 565-568.
7. Peng G, Trock E, Haick H (2008) Detecting simulated patterns of lung cancer biomarkers by random network of singlewalled carbon nanotubes coated with nonpolymeric organic materials. Nano Lett 8: 3631-3635.
8. Peng G, Tisch U, Adams O, Hakim M, Shehada N, et al. (2009) Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol 4: 669-673.
9. McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, et al. (2006) Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther 5: 30-9.
10. Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, et al. (2012) Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J 39: 669-76.
11. Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, et al. (2009) Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 64: 744-748.
12. Junger M, Bödeker, Baumbach JI (2010) Peak assignment in multi-capillary column -ion mobility spectrometry using comparative studies with gas chromatography-mass spectrometry for exhalred breath analysis. Anal Bioanal Chem 396: 471-482.
13. Bunkowski A, Boedeker B, Bader S, Westhoff M, Litterst P, et al. (2009) MCC/IMS signals in human breath related to sarcoidosis-results of a feasibility study using an automated peak finding procedure. J Breath Res 3: 046001.
14. Westhoff M, Litterst P, Freitag L, Baumbach JI (2007). Ion mobility spectrometry in the diagnosis of Sarcoidosis: Results of a feasibility study. J Physiol Pharmacol 58: 739-751.
15. Westhoff M, Litterst P, Maddula S, Bödeker B, Rahmann S, et al. (2010) Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Int J Ion Mobil Spectrom 13: 131-139.
16. Baumbach JI (2006) Process analysis using ion mobility spectrometry. Anal Bioanal Chem 384: 1059-1070.
17. Bunkowski A, Maddula S, Davies AN, Westhoff M, Litterst P, et al. (2010) One-year time series of investigations of analytes within human breath using ion mobility spectrometry. Int J Ion Mobil Spectrom13: 141-148.
18. Bödeker B, Davies AN, Maddula S, Baumbach JI (2010) Biomarker validation-room air variation during human breath investigations. Int J Ion Mobil Spectrom.13: 177-184.
19. Maddula S, Blank L, Schmid A, Baumbach JI (2009) Detection of volatile metabolites ofEscherichia coli by multi capillary column coupled ion mobility spectrometry. Anal Bioanal Chem 394: 791-800.
20. Fink T, Baumbach JI, Kreuer S (2014) Ion mobility spectrometry in breath research J Breath Res 8: 027104.
21. Kreuer S, Hauschild A, Fink T, Baumbach JI, Maddula S, et al. (2014) Two different approaches for pharmacokinetic modeling of exhaled drug concentrations. Sci Rep 4: 5423.
22. Bödeker B, Baumbach JI (2009) Analytical Description of IMS-Signals. Int J Ion Mobil Spectrom 12: 103-108.
23. Bödeker B, Vautz W, Baumbach JI (2008) Peak Finding and Referencing in MCC/IMS-Data. Int J Ion Mobil Spectrom 11: 83-88.
24. Bödeker B, Vautz W, Baumbach JI (2008) Peak Comparison in MCC/IMS-Data-Searching for potential biomarkers in human breath data. Int J Ion Mobil Spectrom 11: 89-93.
25. Bödeker B, Vautz W, Baumbach JI (2008) Visualisation of MCC/IMS-Data. Int J Ion Mobil Spectrom 11: 77-81.
26. Bader S, Urfer W, Baumbach JI (2007) Reduction of ion mobility spectrometry data by clustering characteristic peak structures. J Chemom 20: 128-135.
27. Smolinska A, Hauschild AC, Fijten RR, Dallinga JW, Baumbach J, et al. (2014) Current breathomicsa review on data pre-processing techniques and machine learning in metabolomics breath analysis. J Breath Res 8: 027105.
28. Schneider T, Hauschild AC, Baumbach JI, Baumbach J (2013) An integrative clinical database and diagnostics platform for biomarker identification and analysis in ion mobility spectra of human exhaled air. J Integr Bioinform 10: 218.
29. Hauschild AC, Kopczynski D, D'Addario M, Baumbach JI, Rahmann S, et al. (2013) Peak Detection Method Evaluation for Ion Mobility Spectrometry by Using Machine Learning Approaches. Metabolites 3: 277-293.
30. Hauschild AC, Schneider T, Pauling J, Rupp K, Jang M, et al. (2012) Computational Methods for Metabolomic Data Analysis of Ion Mobility Spectrometry Data-Reviewing the State of the Art. Metabolites 2: 733-755.
31. Hauschild AC, Baumbach JI, Baumbach JI (2012) Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identification. Genet Mol Res 11: 2733-2744.
32. Westhoff M, Litterst P, Maddula S, Bödeker B, Baumbach JI et al. (2011) Statistical and bioinformatical methods to differentiate chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control by breath analysis using ion mobility spectrometr. Int J Ion Mobil Spectrom 11: 139-149.
33. Baumbach JI, Maddula S, Sommerwerck U, Besa V, Kurth I, et al. (2011) Significant different volatile biomarker during bronchoscopic ion mobility spectrometry investigation of patients suffering lung carcinoma. Int J Ion Mobil Spectrom 14: 159-166.
34. Maddula S, Rupp K, Baumbach JI (2012) Recommendation for an upgrade to the standard format in order to cross-link the GC/MSD and the MCC/IMS data. Int J Ion Mobil Spectrom 15: 79-81.
35. Mazzone PJ (2010) Exhaled volatile organic compounds as biomarkers for respiratory diseases. European respiratory monograph 49: 130-139.
36. Darwiche K, Baumbach I.J, Sommerwerck U, Teschler H, Freitag L (2011) Bronchoscopically Obtained Volatile Biomarkers in Lung Cancer. Lung 189: 445-52.
37. Baumbach IJ, Maddula S, Sommerwerck U, Besa V, Kurth I, et al. (2011) Significant different volatile biomarker during bronchoscopic ion mobility spectrometry investigation of patients suffering lung carcinoma. Int J Ion Mobil Spectrom 14: 159-166.
38. Broët P, Dalmasso C, Tan EH, Alifano M, Zhang S, et al. (2011) Genomic profiles specific to patient ethnicity in lung adenocarcinoma. Clin Cancer Res 17: 3542-3550.
39. Saijo N, Fukuoka M, Thongprasert S, Ichinose Y, Mitsudomi T, et al. (2010) Lung cancer working group report. Jpn J Clin Oncol 4: i7-12.
40. Mitsudomi T, Yatabe Y (2007) Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci 98: 1817-1824.
41. Pao W, Hutchinson KE (2012) Chipping away at the lung cancer genome. Nat Med 18: 349-351.
42. Pao W, Girard N (2011) New driver mutations in non-small-cell lung cancer. Lancet Oncol 12: 175-180.
43. rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143: e30S-39S.
44. Paradiso A, Tommasi S, Pinto R, Carpagnano GE, Foschino-Barbaro MP (2008) Exhaled breath condensate is not suitable to detect EGFR somatic mutations. Eur Respir J 32: 1126-1127.
45. Zhang D, Takigawa N, Ochi N, Tanimoto T, Noujima D, et al. (2011) Detection of the EGFR mutation in exhaled breath condensate from a heavy smoker with squamous cell carcinoma of the lung. Lung Cancer 73: 379-380.